Vetr Advises Hold On Sarepta By: Benzinga via Benzinga March 07, 2017 at 06:48 AM EST The Vetr crowd on Monday upgraded their rating for Sarepta Therapeutics Inc (NASDAQ: SRPT) from 1.5 stars (Strong Sell), issued eight ... Read More >> Related Stocks: Sarepta Therapeutics